Abstract

In humans and other vertebrate animals, vitamin K 2,3-epoxide reductase (VKOR) family enzymes are the gatekeepers between nutritionally acquired K vitamins and the vitamin K cycle responsible for posttranslational modifications that confer biological activity upon vitamin K-dependent proteins with crucial roles in hemostasis, bone development and homeostasis, hormonal carbohydrate regulation and fertility. We report a phylogenetic analysis of the VKOR family that identifies five major clades. Combined phylogenetic and site-specific conservation analyses point to clade-specific similarities and differences in structure and function. We discovered a single-site determinant uniquely identifying VKOR homologs belonging to human pathogenic, obligate intracellular prokaryotes and protists. Building on previous work by Sevier et al. (Protein Science 14:1630), we analyzed structural data from both VKOR and prokaryotic disulfide bond formation protein B (DsbB) families and hypothesize an ancient evolutionary relationship between the two families where one family arose from the other through a gene duplication/deletion event. This has resulted in circular permutation of primary sequence threading through the four-helical bundle protein folds of both families. This is the first report of circular permutation relating distant α-helical membrane protein sequences and folds. In conclusion, we suggest a chronology for the evolution of the five extant VKOR clades.

Highlights

  • In humans and other animals, vitamin K 2,3-epoxide complex subunit 1 (VKORC1) is the primary oxidoreductase enzyme that reduces vitamin K quinone (K), acquired in trace amounts by dietary uptake, to the hydroquinone (KH2 ) form, functioning as the point of entry for vitamin K into the vitaminK cycle [1,2,3]

  • Family (327 sequences, truncated to residues corresponding to human VKORC1: Leu13-Phe150 in order to remove highly variable N- and C-terminal sequences) and disulfide bond formation protein B (DsbB) family

  • Previous reports have suggested that transmembrane helices (TMHs) considerably contribute to phylogenetic noise, due to high frequency of occurrance and degeneracy among nonpolar residues in the hydrophobic membrane core and a relatively low selection pressure on residues that face into the lipid bilayer [50,51]

Read more

Summary

Introduction

In humans and other animals, vitamin K 2,3-epoxide complex subunit 1 (VKORC1) is the primary oxidoreductase enzyme that reduces vitamin K quinone (K), acquired in trace amounts by dietary uptake, to the hydroquinone (KH2 ) form, functioning as the point of entry for vitamin K into the vitaminK cycle [1,2,3]. In humans and other animals, vitamin K 2,3-epoxide complex subunit 1 (VKORC1) is the primary oxidoreductase enzyme that reduces vitamin K quinone (K), acquired in trace amounts by dietary uptake, to the hydroquinone (KH2 ) form, functioning as the point of entry for vitamin K into the vitamin. In the case of pathological hypercoagulative conditions such as thrombosis and embolism, 4-hydroxycoumarin based oral anticoagulants, including warfarin as a well-known example, are administered to block the enzymatic function of VKORC1, effectively diminishing turnover of the vitamin K cycle [6]. This results in induction of a controlled hypocoagulative state to counteract the tendency towards clot formation. Evidence has been presented that a second VKOR enzyme, VKORC1-like 1 (VKORC1L1), is responsible for extrahepatic

Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.